Successful treatment of active ankylosing spondylitis with the anti–tumor necrosis factor α monoclonal antibody infliximab
✍ Scribed by Jan Brandt; Hildrun Haibel; Daniel Cornely; Werner Golder; José Gonzalez; Jaqueline Reddig; Wolfgang Thriene; Joachim Sieper; Jürgen Braun
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 584 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective To estimate the incidence of anterior uveitis in patients with ankylosing spondylitis (AS) who underwent anti–tumor necrosis factor (anti‐TNF) therapy, using data from recently performed trials. ## Methods Data from 4 placebo‐controlled studies with anti‐TNF agents in AS
## Abstract ## Objective To confirm in a placebo‐controlled trial the safety and efficacy profile of infliximab in short‐term treatment of patients with active spondylarthropathy (SpA). ## Methods Forty patients with active SpA were randomly assigned to receive an intravenous loading dose (weeks